Arch Oncology
Latest round
- Series C
Last raised
- Apr 2021
Total raised
- $155M
Investors
- 11
About Arch Oncology
Founded in 2006 in Brisbane, US, Arch Oncology, Inc. develops monoclonal antibodies targeting cancer cells.Arch Oncology specializes in innovative therapeutic solutions for oncology, primarily developing monoclonal antibodies and biologics targeting cancer cells.Arch Oncology generates revenue through partnerships and collaborations with pharmaceutical firms and direct sales of their therapeutic products.
Who invested in Arch Oncology
11 investors across 2 rounds
See all investors in Arch Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arch Oncology
Who invested in Arch Oncology?
Arch Oncology has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arch Oncology raised?
Arch Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Arch Oncology last raise money?
Arch Oncology's most recent round on record is a Series C, in Apr 2021.
What does Arch Oncology do?
Founded in 2006 in Brisbane, US, Arch Oncology, Inc.
Where is Arch Oncology headquartered?
Arch Oncology is headquartered in Brisbane, US.
Which VCs invest in companies like Arch Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arch Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Arch Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.